ARUNA BIO INC.

In News

Aruna Bio Announces FDA Clearance of IND for Lead Program AB126, Enabling the First Exosome to Enter in Human Clinical Trials for a Neurological Indication - BioInformant

BioInformant - Apr 06, 2024

Vicarious Surgical Hires Stephen From as CEO - Medical Product Outsourcing

Medical Product Outsourcing - Aug 04, 2025

Robotic surgery heats up with clearances and clinical trials - Modern Healthcare

Modern Healthcare - Aug 19, 2025

Research startup develops new stroke patient therapies - UGA Today

UGA Today - Feb 24, 2021

Aruna Bio Announces Issuance of a New Composition of Matter Patent Covering Neural Exosomes in Japan - BioInformant

BioInformant - Jun 24, 2022

Medtech firms shuffle execs in 2025 - MedTech Dive

MedTech Dive - Aug 25, 2025

Global pharmaceutical manufacturer Syngene selects Maryland - business.maryland.gov

business.maryland.gov - Aug 12, 2025

JPMorgan Flags 3 Stocks With the Ingredients for a Short Squeeze - Business Insider

Business Insider - Sep 25, 2025

Arun Kumar , Harnaut candidate Bihar Election bio : Assets , Total Income , Liabilities , Criminal Cases and other details. - The Hindu

The Hindu - May 24, 2026

Exosome Therapies Market Poised for Explosive Growth During the Study Period (2025-2034) | DelveInsight - PR Newswire

PR Newswire - Jan 13, 2025

Six exosome therapy companies driving development in the field - Labiotech.eu

Labiotech.eu - Nov 14, 2024

Exosome Therapeutics Are Paving a Path to Clinical Readiness - BioSpace

BioSpace - Mar 04, 2024

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment